Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice

Journal of Lipid Research

Volumn 53, Issue 1, 2012, Pages 105-118

  Kok, Bernard P C ^a   Kienesberger, Petra C ^a   Dyck, Jason R B ^a   Brindley, David N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

oxidation; Fatty acid esterification; Lipolysis; mTOR; Perfused hearts; Phosphatidate phosphatase

Indexed keywords

GLUCOSE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; OLEIC ACID; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL; PROTEIN LIPIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; EX VIVO STUDY; FATTY ACID METABOLISM; FATTY LIVER DYSTROPHY; FEMALE; GLUCOSE METABOLISM; HEART DISEASE; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART PERFORMANCE; HEART PERFUSION; IN VIVO STUDY; LIVER DISEASE; MALE; MOUSE; NONHUMAN; OLEATE METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; FATTY LIVER; GLUCOSE; HEART; MALE; MICE; MYOCARDIUM; NUCLEAR PROTEINS; OLEIC ACID; PHOSPHATIDATE PHOSPHATASE; TRIGLYCERIDES;

EID: 84455161545     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M019430     Document Type: Article

References (81)

1. Stanley, W. C., F. A. Recchia, and G. D. Lopaschuk. 2005. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85: 1093-1129. (Pubitemid 40894649)
2. Lopaschuk, G. D., J. R. Ussher, C. D. Folmes, J. S. Jaswal, and W. C. Stanley. 2010. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90: 207-258.
3. Saddik, M., and G. D. Lopaschuk. 1991. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J. Biol. Chem. 266: 8162-8170. (Pubitemid 21906491)
4. Lewis, G. F., A. Carpentier, K. Adeli, and A. Giacca. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23: 201-229. (Pubitemid 34299024)
5. McArthur, M. D., S. E. Graham, J. C. Russell, and D. N. Brindley. 1998. Exaggerated stress-induced release of nonesterified fatty acids in JCR:LA-corpulent rats. Metabolism. 47: 1383-1390. (Pubitemid 28523473)
6. Boudina, S., S. Sena, H. Theobald, X. Sheng, J. J. Wright, X. X. Hu, S. Aziz, J. I. Johnson, H. Bugger, V. G. Zaha, et al. 2007. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 56: 2457-2466. (Pubitemid 47523253)
7. Buchanan, J., P. K. Mazumder, P. Hu, G. Chakrabarti, M. W. Roberts, U. J. Yun, R. C. Cooksey, S. E. Litwin, and E. D. Abel. 2005. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 146: 5341-5349. (Pubitemid 41653047)
8. Aasum, E., M. Cooper, D. L. Severson, and T. S. Larsen. 2005. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice. Can. J. Physiol. Pharmacol. 83: 183-190. (Pubitemid 40695392)
9. Boudina, S., and E. D. Abel. 2006. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda). 21: 250-258. (Pubitemid 44156857)
10. Brindley, D. N., B. P. Kok, P. C. Kienesberger, R. Lehner, and J. R. Dyck. 2010. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am. J. Physiol. Endocrinol. Metab. 298: E897-E908.
11. Reue, K., and D. N. Brindley. 2008. Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism. J. Lipid Res. 49: 2493-2503.
12. Liu, L., X. Shi, K. G. Bharadwaj, S. Ikeda, H. Yamashita, H. Yagyu, J. E. Schaffer, Y. H. Yu, and I. J. Goldberg. 2009. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J. Biol. Chem. 284: 36312-36323.
13. Banke, N. H., A. R. Wende, T. C. Leone, J. M. O'Donnell, E. D. Abel, D. P. Kelly, and E. D. Lewandowski. 2010. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ. Res. 107: 233-241.
14. Donkor, J., M. Sariahmetoglu, J. Dewald, D. N. Brindley, and K. Reue. 2007. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J. Biol. Chem. 282: 3450-3457. (Pubitemid 47084457)
15. Harris, T. E., T. A. Huffman, A. Chi, J. Shabanowitz, D. F. Hunt, A. Kumar, and J. C. Lawrence, Jr. 2007. Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J. Biol. Chem. 282: 277-286. (Pubitemid 47076630)
16. Reue, K., P. Xu, X. P. Wang, and B. G. Slavin. 2000. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J. Lipid Res. 41: 1067-1076. (Pubitemid 30483010)
17. Péterfy, M., J. Phan, P. Xu, and K. Reue. 2001. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 27: 121-124. (Pubitemid 32044532)
18. Langner, C. A., E. H. Birkenmeier, O. Ben-Zeev, M. C. Schotz, H. O. Sweet, M. T. Davisson, and J. I. Gordon. 1989. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue specific defects in lipoprotein lipase and hepatic lipase activities. J. Biol. Chem. 264: 7994-8003. (Pubitemid 19137280)
19. Phan, J., M. Péterfy, and K. Reue. 2004. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J. Biol. Chem. 279: 29558-29564. (Pubitemid 38915837)
20. Gazit, V., A. Weymann, E. Hartman, B. N. Finck, P. W. Hruz, A. Tzekov, and D. A. Rudnick. 2010. Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology. 52: 2109-2117.
21. Langner, C. A., E. H. Birkenmeier, K. A. Roth, R. T. Bronson, and J. I. Gordon. 1991. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J. Biol. Chem. 266: 11955-11964. (Pubitemid 21907042)
22. Nadra, K., A. S. de Preux Charles, J. J. Medard, W. T. Hendriks, G. S. Han, S. Gres, G. M. Carman, J. S. Saulnier-Blache, M. H. Verheijen, and R. Chrast. 2008. Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev. 22: 1647-1661. (Pubitemid 351846844)
23. Finck, B. N., M. C. Gropler, Z. Chen, T. C. Leone, M. A. Croce, T. E. Harris, J. C. Lawrence, Jr., and D. P. Kelly. 2006. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 4: 199-210. (Pubitemid 44283957)
24. Péterfy, M., J. Phan, and K. Reue. 2005. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J. Biol. Chem. 280: 32883-32889. (Pubitemid 41368337)
25. Manmontri, B., M. Sariahmetoglu, J. Donkor, M. B. Khalil, M. Sundaram, Z. Yao, K. Reue, R. Lehner, and D. N. Brindley. 2008. Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. J. Lipid Res. 49: 1056-1067.
26. Whiting, P. H., M. Bowley, R. G. Sturton, P. H. Pritchard, D. N. Brindley, and J. N. Hawthorne. 1977. The effect of chronic diabetes, induced by streptozotocin, on the activities of some enzymes of glycerolipid synthesis in rat liver. Biochem. J. 168: 147-153. (Pubitemid 8224065)
27. Schoonderwoerd, K., S. Broekhoven-Schokker, W. C. Hülsmann, and H. Stam. 1990. Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes. Biochem. J. 268: 487-492. (Pubitemid 20193993)
28. Zhang, P., L. O'Loughlin, D. N. Brindley, and K. Reue. 2008. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J. Lipid Res. 49: 1519-1528.
29. Cascales, C., E. H. Mangiapane, and D. N. Brindley. 1984. Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes. Biochem. J. 219: 911-916. (Pubitemid 14141749)
30. Swanton, E. M., and E. D. Saggerson. 1997. Glycerolipid metabolizing enzymes in rat ventricle and in cardiac myocytes. Biochim. Biophys. Acta. 1346: 93-102. (Pubitemid 27220314)
31. Burgdorf, C., L. Hansel, M. Heidbreder, O. Johren, F. Schutte, H. Schunkert, and T. Kurz. 2009. Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus. Biochem. Biophys. Res. Commun. 390: 165-170.
32. Jamal, Z., A. Martin, A. Gómez-Muñoz, P. Hales, E. Chang, J. C. Russell, and D. N. Brindley. 1992. Phosphatidate phosphohydrolases in liver, heart and adipose tissue of the JCR:LA corpulent rat and the lean genotypes: implications for glycerolipid synthesis and signal transduction. Int. J. Obes. Relat. Metab. Disord. 16: 789-799.
33. Loos, R. J., T. Rankinen, L. Perusse, A. Tremblay, J. P. Despres, and C. Bouchard. 2007. Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism. Obesity (Silver Spring). 15: 2723-2732.
34. Wiedmann, S., M. Fischer, M. Koehler, K. Neureuther, G. Riegger, A. Doering, H. Schunkert, C. Hengstenberg, and A. Baessler. 2008. Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes. 57: 209-217.
35. Donkor, J., L. M. Sparks, H. Xie, S. R. Smith, and K. Reue. 2008. Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J. Clin. Endocrinol. Metab. 93: 233-239.
36. Dolinsky, V. W., J. S. Morton, T. Oka, I. Robillard-Frayne, M. Bagdan, G. D. Lopaschuk, C. Des Rosiers, K. Walsh, S. T. Davidge, and J. R. Dyck. 2010. Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat. Hypertension. 56: 412-421.
37. Tei, C., L. H. Ling, D. O. Hodge, K. R. Bailey, J. K. Oh, R. J. Rodeheffer, A. J. Tajik, and J. B. Seward. 1995. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. J. Cardiol. 26: 357-366. (Pubitemid 26011184)
38. Dyck, J. R., J. F. Cheng, W. C. Stanley, R. Barr, M. P. Chandler, S. Brown, D. Wallace, T. Arrhenius, C. Harmon, G. Yang, et al. 2004. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ. Res. 94: e78-e84.
39. Martin, A., A. Gómez-Muñoz, Z. Jamal, and D. N. Brindley. 1991. Characterization and assay of phosphatidate phosphatase. Methods Enzymol. 197: 553-563.
40. 2+ requirements of phosphatidate phosphohydrolase in cytosolic and microsomal fractions of rat liver. Biochem. J. 245: 347-355.
41. Waggoner, D. W., A. Gómez-Muñoz, J. Dewald, and D. N. Brindley. 1996. Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate. J. Biol. Chem. 271: 16506-16509. (Pubitemid 26239002)
42. Pilquil, C., J. Dewald, A. Cherney, I. Gorshkova, G. Tigyi, D. English, V. Natarajan, and D. N. Brindley. 2006. Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migration by controlling phospholipase D2-dependent phosphatidate generation. J. Biol. Chem. 281: 38418-38429. (Pubitemid 46041965)
43. Martin, A., P. A. Duffy, C. Liossis, A. Gómez-Muñoz, L. O'Brien, J. C. Stone, and D. N. Brindley. 1997. Increased concentrations of phosphatidate, diacylglycerol and ceramide in ras- and tyrosine kinase (fps)-transformed fibroblasts. Oncogene. 14: 1571-1580. (Pubitemid 27182840)
44. Kuang, M., M. Febbraio, C. Wagg, G. D. Lopaschuk, and J. R. Dyck. 2004. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation. 109: 1550-1557. (Pubitemid 38420185)
45. Jaswal, J. S., M. Gandhi, B. A. Finegan, J. R. Dyck, and A. S. Clanachan. 2007. Inhibition of p38 MAPK and AMPK restores adenosine- induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization. Am. J. Physiol. Heart Circ. Physiol. 293: H1107-H1114. (Pubitemid 47254211)
46. Mangiapane, E. H., and D. N. Brindley. 1986. Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem. J. 233: 151-160. (Pubitemid 16063785)
47. Kates, M. 1972. Techniques of lipidology: isolation, analysis and identification of lipids. In: Laboratory Techniques in Biochemistry and Molecular Biology (series), Volume 33, Part II. T. S. Work and E. Work, editors. North-Holland Publishing Company, Amsterdam. 269-469.
48. de Leiris, J., D. P. Harding, and S. Pestre. 1984. The isolated perfused rat heart: a model for studying myocardial hypoxia or ischaemia. Basic Res. Cardiol. 79: 313-321. (Pubitemid 14075523)
49. Fraser, H., G. D. Lopaschuk, and A. S. Clanachan. 1998. Assessment of glycogen turnover in aerobic, ischemic, and reperfused working rat hearts. Am. J. Physiol. 275: H1533-H1541.
50. Mitra, M. S., J. D. Schilling, X. Wang, P. Y. Jay, J. M. Huss, X. Su, and B. N. Finck. 2011. Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor gamma coactivator 1alpha/estrogen related receptor axis. J. Mol. Cell. Cardiol. 51: 120-128.
51. Brindley, D. N. 2004. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer. J. Cell. Biochem. 92: 900-912. (Pubitemid 44264240)
52. Ellis, J. M., S. M. Mentock, M. A. Depetrillo, T. R. Koves, S. Sen, S. M. Watkins, D. M. Muoio, G. W. Cline, H. Taegtmeyer, G. I. Shulman, et al. 2011. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy. Mol. Cell. Biol. 31: 1252-1262.
53. Linn, T. C., F. H. Pettit, F. Hucho, and L. J. Reed. 1969. Alpha-keto acid dehydrogenase complexes. XI. Comparative studies of regulatory properties of the pyruvate dehydrogenase complexes from kidney, heart, and liver mitochondria. Proc. Natl. Acad. Sci. USA. 64: 227-234.
54. Listenberger, L. L., X. Han, S. E. Lewis, S. Cases, R. V. Farese, Jr., D. S. Ory, and J. E. Schaffer. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA. 100: 3077-3082. (Pubitemid 36356542)
55. Ostrander, D. B., G. C. Sparagna, A. A. Amoscato, J. B. McMillin, and W. Dowhan. 2001. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J. Biol. Chem. 276: 38061-38067.
56. Vasdev, S. C., and K. J. Kako. 1977. Incorporation of fatty acids into rat heart lipids. In vivo and in vitro studies. J. Mol. Cell. Cardiol. 9: 617-631. (Pubitemid 8162629)
57. Reibel, D. K., B. O'Rourke, K. A. Foster, H. Hutchinson, C. E. Uboh, and R. L. Kent. 1986. Altered phospholipid metabolism in pressureoverload hypertrophied hearts. Am. J. Physiol. 250: H1-H6.
58. O'Neil, T. K., L. R. Duffy, J. W. Frey, and T. A. Hornberger. 2009. The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions. J. Physiol. 587: 3691-3701.
59. Fang, Y., M. Vilella-Bach, R. Bachmann, A. Flanigan, and J. Chen. 2001. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science. 294: 1942-1945. (Pubitemid 33101594)
60. Sengupta, S., T. R. Peterson, and D. M. Sabatini. 2010. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell. 40: 310-322.
61. Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell. 124: 471-484. (Pubitemid 43199434)
62. Bachar, E., Y. Ariav, M. Ketzinel-Gilad, E. Cerasi, N. Kaiser, and G. Leibowitz. 2009. Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells via activation of mTORC1. PLoS ONE. 4: e4954.
63. Ozcan, U., L. Ozcan, E. Yilmaz, K. Duvel, M. Sahin, B. D. Manning, and G. S. Hotamisligil. 2008. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol. Cell. 29: 541-551. (Pubitemid 351384644)
64. Calfon, M., H. Zeng, F. Urano, J. H. Till, S. R. Hubbard, H. P. Harding, S. G. Clark, and D. Ron. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 415: 92-96. (Pubitemid 34062456)
65. Gomez-Muñoz, A., E. H. Hamza, and D. N. Brindley. 1992. Effects of sphingosine, albumin and unsaturated fatty acids on the activation and translocation of phosphatidate phosphohydrolases in rat hepatocytes. Biochim. Biophys. Acta. 1127: 49-56.
66. Phan, J., and K. Reue. 2005. Lipin, a lipodystrophy and obesity gene. Cell Metab. 1: 73-83. (Pubitemid 43960586)
67. Xu, J., W. N. Lee, J. Phan, M. F. Saad, K. Reue, and I. J. Kurland. 2006. Lipin deficiency impairs diurnal metabolic fuel switching. Diabetes. 55: 3429-3438. (Pubitemid 44923602)
68. Donkor, J., P. Zhang, S. Wong, L. O'Loughlin, J. Dewald, B. P. Kok, D. N. Brindley, and K. Reue. 2009. A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2. J. Biol. Chem. 284: 29968-29978.
69. Grimsey, N., G. S. Han, L. O'Hara, J. J. Rochford, G. M. Carman, and S. Siniossoglou. 2008. Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2. J. Biol. Chem. 283: 29166-29174.
70. Xu, H. E., M. H. Lambert, V. G. Montana, D. J. Parks, S. G. Blanchard, P. J. Brown, D. D. Sternbach, J. M. Lehmann, G. B. Wisely, T. M. Willson, et al. 1999. Molecular recognition of fatty acids by peroxisome proliferator activated receptors. Mol. Cell. 3: 397-403. (Pubitemid 29290680)
71. Manning, R., and D. N. Brindley. 1972. Tritium isotope effects in the measurement of the glycerol phosphate and dihydroxyacetone phosphate pathways of glycerolipid biosynthesis in rat liver. Biochem. J. 130: 1003-1012.
72. Ko, K. W., B. Erickson, and R. Lehner. 2009. Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes. Biochim. Biophys. Acta. 1791: 1133-1143.
73. Zhang, Q. X., C. S. Pilquil, J. Dewald, L. G. Berthiaume, and D. N. Brindley. 2000. Identification of structurally important domains of lipid phosphate phosphatase-1: implications for its sites of action. Biochem. J. 345: 181-184. (Pubitemid 30077155)
74. Hopewell, R., P. Martin-Sanz, A. Martin, J. Saxton, and D. N. Brindley. 1985. Regulation of the translocation of phosphatidate phosphohydrolase between the cytosol and the endoplasmic reticulum of rat liver. Effects of unsaturated fatty acids, spermine, nucleotides, albumin and chlorpromazine. Biochem. J. 232: 485-491. (Pubitemid 16210782)
75. 14C]oleate incorporated into lipids in the perfused rat heart: a comparison under isothermal and hypothermic conditions. J. Mol. Cell. Cardiol. 10: 439-448.
76. Hvattum, E., S. Uran, A. G. Sandbaek, A. A. Karlsson, and T. Skotland. 2006. Quantification of phosphatidylserine, phosphatidic acid and free fatty acids in an ultrasound contrast agent by normal-phase high-performance liquid chromatography with evaporative light scattering detection. J. Pharm. Biomed. Anal. 42: 506-512. (Pubitemid 44375102)
77. Stith, B. J., J. Hall, P. Ayres, L. Waggoner, J. D. Moore, and W. A. Shaw. 2000. Quantification of major classes of Xenopus phospholipids by high performance liquid chromatography with evaporative light scattering detection. J. Lipid Res. 41: 1448-1454.
78. Brindley, D. N., D. Allan, and R. H. Michell. 1975. Letter: the redirection of glyceride and phospholipid synthesis by drugs including chlorpromazine, fenfluramine, imipramine, mepyramine and local anaesthetics. J. Pharm. Pharmacol. 27: 462-464.
79. Boluyt, M. O., Z. B. Li, A. M. Loyd, A. F. Scalia, G. M. Cirrincione, and R. R. Jackson. 2004. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Cardiovasc. Drugs Ther. 18: 257-267. (Pubitemid 39222168)
80. Inoki, K., H. Mori, J. Wang, T. Suzuki, S. Hong, S. Yoshida, S. M. Blattner, T. Ikenoue, M. A. Ruegg, M. N. Hall, et al. 2011. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J. Clin. Invest. 121: 2181-2196.
81. Düvel, K., J. L. Yecies, S. Menon, P. Raman, A. I. Lipovsky, A. L. Souza, E. Triantafellow, Q. Ma, R. Gorski, S. Cleaver, et al. 2010. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell. 39: 171-183.